Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Equity (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Return on Equity for 15 consecutive years, with 0.01% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Equity rose 28.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 28.0% increase, with the full-year FY2025 number at 0.01%, up 25.0% from a year prior.
  • Return on Equity was 0.01% for Q4 2025 at Anika Therapeutics, up from 0.13% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.04% in Q2 2024 to a low of 0.32% in Q2 2025.
  • A 5-year average of 0.07% and a median of 0.04% in 2022 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 28bps in 2025; the steepest drop was -36bps in 2025.
  • Anika Therapeutics' Return on Equity stood at 0.01% in 2021, then tumbled by -195bps to 0.01% in 2022, then fell by -29bps to 0.02% in 2023, then crashed by -1533bps to 0.28% in 2024, then surged by 98bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Return on Equity are 0.01% (Q4 2025), 0.13% (Q3 2025), and 0.32% (Q2 2025).